Moreover, analysis of differential gene expression using The Cancer Genome Atlas (TCGA) RNASeq data set revealed that overall Cep131 expression level based on average normalized read count is high in several cancers, such as uterine, bladder, lung, kidney, breast, and colon (Table S2 and Fig. S8b). This evidence concerns the gene CEP131 and cancer.